Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$978M |
| 2 |
Microsoft
MSFT
|
+$812M |
| 3 |
Bank of America
BAC
|
+$602M |
| 4 |
Apple
AAPL
|
+$518M |
| 5 |
NVIDIA
NVDA
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.32B |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.12B |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$958M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$940M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.45% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 11.27% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Nu Holdings
NU
$66.9B
| $3.17M | ﹤0.01% |
437,910
-203,158
| -32% | -$1.52M |
|
1577
ChargePoint
CHPT
$161M
| $3.17M | ﹤0.01% |
31,891
-7,212
| -18% | -$1.05M |
|
1578
Rocket Pharmaceuticals
RCKT
$394M
| $3.16M | ﹤0.01% |
154,409
+11,192
| +8% | +$203K |
|
1579
Independence Realty Trust
IRT
$4.07B
| $3.16M | ﹤0.01% |
224,721
-27,427
| -11% | -$452K |
|
|
SUM
1580
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $3.16M | ﹤0.01% |
101,440
+36,853
| +57% | +$1.31M |
|
1581
Novanta
NOVT
$5.92B
| $3.15M | ﹤0.01% |
21,994
-4,783
| -18% | -$779K |
|
|
KNSW.WS
1582
DELISTED
KnightSwan Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
KNSW.WS
| $3.15M | ﹤0.01% |
300,000
| – | – |
|
|
SRCL
1583
DELISTED
Stericycle Inc
SRCL
| $3.15M | ﹤0.01% |
70,408
+16,505
| +31% | +$737K |
|
1584
Cavco Industries
CVCO
$4.55B
| $3.15M | ﹤0.01% |
11,848
-407
| -3% | -$114K |
|
1585
Franklin Electric
FELE
$4.84B
| $3.14M | ﹤0.01% |
35,234
-16,852
| -32% | -$1.63M |
|
|
AYX
1586
CALL
DELISTED
Alteryx Inc
AYX
| $3.14M | ﹤0.01% |
+83,200
| New | +$2.98M |
|
|
SOVO
1587
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $3.14M | ﹤0.01% |
139,058
+96,639
| +228% | +$2.03M |
|
1588
Iridium Communications
IRDM
$5.29B
| $3.14M | ﹤0.01% |
68,926
-20,926
| -23% | -$1.08M |
|
1589
Cracker Barrel
CBRL
$1.29B
| $3.14M | ﹤0.01% |
46,653
+20,362
| +77% | +$1.71M |
|
1590
PUT
Accenture
ACN
$108B
| $3.13M | ﹤0.01% |
10,200
-39,000
| -79% | -$12.3M |
|
1591
Starwood Property Trust
STWD
$6.09B
| $3.13M | ﹤0.01% |
161,681
-38,539
| -19% | -$781K |
|
1592
Silicon Laboratories
SLAB
$7.23B
| $3.12M | ﹤0.01% |
26,930
-93,227
| -78% | -$12.9M |
|
|
PPBI
1593
DELISTED
Pacific Premier Bancorp
PPBI
| $3.12M | ﹤0.01% |
143,417
-26,440
| -16% | -$609K |
|
1594
International Bancshares
IBOC
$4.57B
| $3.12M | ﹤0.01% |
71,958
-5,775
| -7% | -$264K |
|
1595
FirstCash
FCFS
$8.78B
| $3.12M | ﹤0.01% |
31,062
-5,458
| -15% | -$516K |
|
1596
Sphere Entertainment
SPHR
$5.73B
| $3.12M | ﹤0.01% |
83,892
-762
| -0.9% | -$28.1K |
|
1597
Matsons
MATX
$6.18B
| $3.11M | ﹤0.01% |
35,078
-3,355
| -9% | -$293K |
|
1598
STAAR Surgical
STAA
$1.21B
| $3.11M | ﹤0.01% |
77,428
+4,426
| +6% | +$207K |
|
1599
Insight Enterprises
NSIT
$4.51B
| $3.11M | ﹤0.01% |
21,372
-3,784
| -15% | -$564K |
|
1600
Merit Medical Systems
MMSI
$5.32B
| $3.1M | ﹤0.01% |
44,909
-11,081
| -20% | -$797K |
|
Similar funds
Barclays's Q3 2023 Portfolio in Review
As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.
- Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
- Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
- Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
- Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
- Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
- Barclays opened 336 new positions and closed 249 in Q3 2023.
- Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.